BioCentury | Jul 7, 2017
Company News
Acer finds public path via Opexa merger
...The Woodlands, Texas Business: Endocrine/Metabolic
Jaime De Leon
ACER-001
ACER-002
celiprolol
Edsivo
imilecleucel-T
T-cell vaccine
Tcelna
Acer Therapeutics Inc.
Opexa Therapeutics Inc.
Adrenergic receptor beta 1 (ADRB1)
Branched chain ketoacid dehydrogenase kinase (BCKDK) (BDK)
T...